These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2064384)

  • 21. Experimental and mathematical modeling methods for the investigation of toxicological interactions.
    El-Masri HA
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):148-54. PubMed ID: 16996550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advancing environmental toxicology through chemical dosimetry: external exposures versus tissue residues.
    McCarty LS; Landrum PF; Luoma SN; Meador JP; Merten AA; Shephard BK; van Wezel AP
    Integr Environ Assess Manag; 2011 Jan; 7(1):7-27. PubMed ID: 21184567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a quantitative model incorporating key events in a hepatotoxic mode of action to predict tumor incidence.
    Luke NS; Sams R; DeVito MJ; Conolly RB; El-Masri HA
    Toxicol Sci; 2010 May; 115(1):253-66. PubMed ID: 20106946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicology and carcinogenesis studies of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (525):1-198. PubMed ID: 17160103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicokinetics and physiologically based toxicokinetics in toxicology and risk assessment.
    Dixit R; Riviere J; Krishnan K; Andersen ME
    J Toxicol Environ Health B Crit Rev; 2003; 6(1):1-40. PubMed ID: 12587252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Framework for evaluation of physiologically-based pharmacokinetic models for use in safety or risk assessment.
    Clark LH; Setzer RW; Barton HA
    Risk Anal; 2004 Dec; 24(6):1697-717. PubMed ID: 15660623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incorporating biologically based models into assessments of risk from chemical contaminants.
    Bull RJ; Conolly RB; De Marini DM; MacPhail RC; Ohanian EV; Swenberg JA
    J Am Water Works Assoc; 1993 Mar; 85(3):49-52. PubMed ID: 11538064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: a progress report.
    Clewell HJ; Thomas RS; Gentry PR; Crump KS; Kenyon EM; El-Masri HA; Yager JW
    Toxicol Appl Pharmacol; 2007 Aug; 222(3):388-98. PubMed ID: 17499324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trichloroethylene and cancer: epidemiologic evidence.
    Scott CS; Cogliano VJ
    Environ Health Perspect; 2000 May; 108 Suppl 2():159-60. PubMed ID: 10807549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a biologically-based controlled growth and differentiation model for developmental toxicology.
    Whitaker SY; Tran HT; Portier CJ
    J Math Biol; 2003 Jan; 46(1):1-16. PubMed ID: 12525932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biologically motivated computational modeling of formaldehyde carcinogenicity in the F344 rat.
    Conolly RB; Kimbell JS; Janszen D; Schlosser PM; Kalisak D; Preston J; Miller FJ
    Toxicol Sci; 2003 Oct; 75(2):432-47. PubMed ID: 12857938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Historical blunders: how toxicology got the dose-response relationship half right.
    Calabrese EJ
    Cell Mol Biol (Noisy-le-grand); 2005 Dec; 51(7):643-54. PubMed ID: 16359616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages.
    Brent RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis.
    Danhof M; de Jongh J; De Lange EC; Della Pasqua O; Ploeger BA; Voskuyl RA
    Annu Rev Pharmacol Toxicol; 2007; 47():357-400. PubMed ID: 17067280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxicology of chemical mixtures: a challenging quest along empirical sciences.
    Groten JP; Heijne WH; Stierum RH; Freidig AP; Feron VJ
    Environ Toxicol Pharmacol; 2004 Dec; 18(3):185-92. PubMed ID: 21782748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Saturable metabolism and its relationship to toxicity.
    Andersen ME
    Crit Rev Toxicol; 1981 May; 9(2):105-50. PubMed ID: 7026174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mode of action and tissue dosimetry in current and future risk assessments.
    Andersen ME; Dennison JE
    Sci Total Environ; 2001 Jul; 274(1-3):3-14. PubMed ID: 11453304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue dosimetry, physiologically-based pharmacokinetic modeling, and cancer risk assessment.
    Andersen ME
    Cell Biol Toxicol; 1989 Dec; 5(4):405-15. PubMed ID: 2627676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.